Page 289 - EJMO-9-2
P. 289
Eurasian Journal of
Medicine and Oncology QGJSF multi-target mechanisms in osteoporosis
therapeutics post-menopausal osteoporosis. Cureus. 14. Quan GH, Wang H, Cao J, et al. Calycosin suppresses
2023;15(8):e42870. RANKL-mediated osteoclastogenesis through inhibition of
doi: 10.7759/cureus.42870 MAPKs and NF-κB. Int J Mol Sci. 2015;16(12):29496-29507.
4. Wang L, Huang X, Qin J, et al. The role of traditional Chinese doi: 10.3390/ijms161226179
medicines in the treatment of osteoporosis. Am J Chin Med. 15. Li N, Tu Y, Shen Y, Qin Y, Lei C, Liu X. Calycosin attenuates
2024;52(4):949-986. osteoporosis and regulates the expression of OPG/RANKL
doi: 10.1142/S0192415X24500393 in ovariectomized rats via MAPK signaling. Pharmazie.
2016;71(10):607-612.
5. Xiong M, Chen X, Wang H, et al. Combining
transcriptomics and network pharmacology to reveal doi: 10.1691/ph.2016.6627
the mechanism of zuojin capsule improving spasmolytic 16. Duan X, Meng Q, Wang C, et al. Calycosin attenuates
polypeptide-expressing metaplasia. J Ethnopharmacol. triglyceride accumulation and hepatic fibrosis in murine
2024;318(Pt B):117075. model of non-alcoholic steatohepatitis via activating
doi: 10.1016/j.jep.2023.117075 farnesoid X receptor. Phytomedicine. 2017;25:83-92.
6. Yu W, Li X, Sun Q, et al. Metabolomics and network doi: 10.1016/j.phymed.2016.12.006
pharmacology reveal the mechanism of Castanopsis honey 17. Li Z, Geng YN, Jiang JD, Kong WJ. Antioxidant and anti-
against Streptococcus pyogenes. Food Chem. 2024;441:138388. inflammatory activities of berberine in the treatment of
doi: 10.1016/j.foodchem.2024.138388 diabetes mellitus. Evid Based Complement Alternat Med.
2014;2014:289264.
7. Zhu H, Wang S, Shan C, et al. Mechanism of protective effect
of xuan-bai-cheng-qi decoction on LPS-induced acute lung doi: 10.1155/2014/289264
injury based on an integrated network pharmacology and 18. Lee JW, Mase N, Yonezawa T, et al. Palmatine attenuates
RNA-sequencing approach. Respir Res. 2021;22(1):188.
osteoclast differentiation and function through inhibition of
doi: 10.1186/s12931-021-01781-1 receptor activator of nuclear factor-κb ligand expression in
osteoblast cells. Biol Pharm Bull. 2010;33(10):1733-1739.
8. Deng TT, Ding WY, Lu XX, et al. Pharmacological and
mechanistic aspects of quercetin in osteoporosis. Front doi: 10.1248/bpb.33.1733
Pharmacol. 2024;15:1338951.
19. Chen ZZ. Berberine induced apoptosis of human
doi: 10.3389/fphar.2024.1338951 osteosarcoma cells by inhibiting phosphoinositide 3 kinase/
protein kinase B (PI3K/Akt) signal pathway activation. Iran
9. Xiong Y, Huang CW, Shi C, et al. Corrigendum: Quercetin
suppresses ovariectomy-induced osteoporosis in rat J Public Health. 2016;45(5):578-585.
mandibles by regulating autophagy and the NLRP3 pathway. 20. Li H, Miyahara T, Tezuka Y, Tran QL, Seto H, Kadota S.
Exp Biol Med (Maywood). 2024;249:10149. Effect of berberine on bone mineral density in SAMP6
doi: 10.3389/ebm.2024.10149 as a senile osteoporosis model. Biol Pharm Bull.
2003;26(1):110-111.
10. Wu S, Zhao F, Zhao J, et al. Dioscin improves postmenopausal
osteoporosis through inducing bone formation and doi: 10.1248/bpb.26.110
inhibiting apoptosis in ovariectomized rats. Biosci Trends. 21. Matsushita K, Itoh S, Ikeda S, Yamamoto Y, Yamauchi Y,
2019;13(5):394-401. Hayashi M. LIF/STAT3/SOCS3 signaling pathway in
doi: 10.5582/bst.2019.01186 murine bone marrow stromal cells suppresses osteoblast
differentiation. J Cell Biochem. 2014;115(7):1262-1268.
11. Tao X, Qi Y, Xu L, et al. Dioscin reduces ovariectomy-induced
bone loss by enhancing osteoblastogenesis and inhibiting doi: 10.1002/jcb.24777
osteoclastogenesis Pharmacol Res. 2020;151:104397. 22. Vimalraj S, Arumugam B, Miranda PJ, Selvamurugan N.
doi: 10.1016/j.phrs.2019.104397 Runx2: Structure, function, and phosphorylation in osteoblast
differentiation. Int J Biol Macromol. 2015;78:202-208.
12. Li M, Yu Y, Xue K, et al. Genistein mitigates senescence of
bone marrow mesenchymal stem cells via ERRα-mediated doi: 10.1016/j.ijbiomac.2015.04.008
mitochondrial biogenesis and mitophagy in ovariectomized 23. Wang L, Yang H, Huang J, et al. Targeted ptpn11 deletion
rats. Redox Biol. 2023;61:102649. in mice reveals the essential role of SHP2 in osteoblast
doi: 10.1016/j.redox.2023.102649 differentiation and skeletal homeostasis. Bone Res.
2021;9(1):6.
13. Wu Z, Liu L. The protective activity of genistein against bone
and cartilage diseases. Front Pharmacol. 2022;13:1016981. doi: 10.1038/s41413-020-00129-7
doi: 10.3389/fphar.2022.1016981 24. Zhou S, Dai Q, Huang X, et al. STAT3 is critical for
Volume 9 Issue 2 (2025) 281 doi: 10.36922/EJMO025150103

